z-logo
open-access-imgOpen Access
Toxicity of uraemia—does it come of AGE?
Author(s) -
G. E. Schreiner
Publication year - 1994
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/9.1.1
Subject(s) - medicine , toxicity , uremia , hemodialysis , pharmacology , intensive care medicine
In the course of normal ageing, and more markedly during hyperglycaemia, proteins are covalently modified and cross-linked through the generation of a family of related adducts which form slowly and irreversibly on most body proteins. Reducing sugars, e.g. glucose, interact with free amino groups to yield Schiff bases; in the course of days these are rearranged to form Amadori products. Over weeks such reversible products are slowly transformed into irreversibly crosslinked advanced glycosylation end-products (AGE); furoyl-furanyl-imidazole (FFI) has been claimed to be one of the cross-linking multifunctional groups, although doubts about its existence in vivo and the possibility of isolation artefacts persist. The acronym AGE was specifically chosen to indicate that a relation exists to the normal ageing process [1]. The AGE reaction depends on the availability of reducing sugars; hence the formation of AGE occurs at a faster rate in patients with diabetes mellitus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom